Venous Disease Clinical Trial
Official title:
A Pilot Study Using AI Algorithms and PPG Technology for the Detection of Venous Diseases
This clinical research aims to evaluate the effectiveness of using Photoplethysmography (PPG) signals combined with Artificial Intelligence (AI) algorithms, for the precise classification and diagnosis of Venous Diseases of the lower limb. This study invites a group of participants who currently undergoing investigations for venous disease at The Whiteley Clinic (hereinafter referred to as TWC). The Participants will be classified into control (healthy individuals with no significant venous disease) and chronic venous disease (CVD) (diagnosed with proven venous disease) groups. Prospective participants who express an interest in being included in the study will be given a patient information sheet and will undergo a briefing of the pilot study. If they consent and sign the relevant consent forms, the participants will perform a series of standardized exercises under the supervision of a consultant vascular surgeon. Throughout the exercises, a data acquisition device attached to the ankle records the PPG signals, capturing the changes in blood volume due to the reflected PPG signals from the red blood cells during the movement. Thus, once the data is collected and recorded, this allows for the analysis of the data of the control group and CVD group against each other. During the analysis of the two groups' PPG signals, the objective lies within the capability to detect subtle nuances in the patterns of the PPG signals during the performed movements using AI algorithms. The AI algorithms will distinguish patterns or features indicating the presence or absence of venous disease. This study seeks to contribute valuable insights into enhancing the diagnosis of venous disease using PPG and AI algorithms, paving novel approaches to Venous healthcare.
Status | Not yet recruiting |
Enrollment | 20 |
Est. completion date | September 2024 |
Est. primary completion date | July 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - Patients are attending for investigation of suspected venous disease. Patients must be able to walk and mobile normally and have good skin integrity of the lower leg, where the PPG is attached. All patients attending TWC are 18 years or older. Exclusion Criteria: - Subjects with known arterial occlusive disease or physical disability affecting gait or ankle movement will be excluded. Patients unable to have a PPG attached to the lower leg (ie: active ulceration) will be excluded. Patients unable to give consent. Pregnant female. |
Country | Name | City | State |
---|---|---|---|
United Kingdom | The Whiteley Clinic | Guildford |
Lead Sponsor | Collaborator |
---|---|
The Whiteley Clinic |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Diagnostic Accuracy of an AI Model for Venous Disease Detection Using PPG Signals | The primary outcome measure of this study is to evaluate the diagnostic accuracy of an AI model in detecting venous disease through the using PPG signals. This will be quantified by assessing the sensitivity and specificity of the AI model when analysing PPG signals from healthy participants without venous diease, and non-healthy participants with venous disease, without the need for direct intervention of a vascular consultant. These results will help evaluate the AI model in terms of how accurately it can identify Venous disease. | June 2024 - September 2024 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05633277 -
Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections
|
N/A | |
Completed |
NCT04758728 -
Adrenaline Reduces Ecchymoses and Hematomas and Improves Quality of Life After Classic Saphenous Vein Stripping
|
N/A | |
Recruiting |
NCT05409976 -
The GORE® VIAFORT Vascular Stent IVC Study
|
N/A | |
Completed |
NCT06395025 -
Blinded User Study for the Evaluation of the Acceptability and Efficacy of One Medical Device in Venous Return in Comparison With a Control Group
|
N/A | |
Not yet recruiting |
NCT04358497 -
Endovascular Versus Medical Treatment for the Pelvic Congestion Syndrome
|
Phase 4 | |
Completed |
NCT03703765 -
Volume Estimation of the Limb After VEnous Treatment
|
N/A | |
Completed |
NCT01368159 -
Efficacy on Pain Following a Procedure for Injecting Sclerotherapeutic Foam Into the Great Saphenous Vein
|
Phase 4 | |
Recruiting |
NCT05628948 -
Vascular Lab Resource (VLR) Biorepository
|
||
Completed |
NCT06153680 -
Consumer Study for the Evaluation of the Usability and Efficacy of One Medical Device in Venous Return
|
N/A | |
Terminated |
NCT03363633 -
Perforator Vein Injection for Symptomatic Venous Disease
|
N/A | |
Recruiting |
NCT05489588 -
The GORE® VIAFORT Vascular Stent Iliofemoral Study
|
N/A | |
Completed |
NCT02655887 -
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
|
N/A | |
Recruiting |
NCT05050799 -
US Post-Market Surveillance Study of the Surfacer System
|
||
Completed |
NCT01993914 -
Prevalence of MTHFR Polymorphisms in Venous Disease
|
N/A | |
Active, not recruiting |
NCT04138134 -
Autophagy and Venous Endothelial Function
|
||
Terminated |
NCT04964817 -
HFpEF and Symptomatic Obstructive Iliofemoral Venous Disease Study
|
||
Recruiting |
NCT02139085 -
Great Saphenous Vein Electrocoagulation
|
Phase 2 | |
Completed |
NCT01509599 -
Cooling Lower Leg Skin to Prevent Venous Leg Ulcers in Patients With Poor Vein Circulation
|
Phase 1/Phase 2 | |
Terminated |
NCT03630185 -
A Comparison of Custom-manufactured vs. Off-the-rack (OTR) Compression Hosiery for Initial Management of Venous Disease
|
N/A |